Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.
Collette Y, Prébet T, Goubard A, Adélaïde J, Castellano R, Carbuccia N, Garnier S, Guille A, Arnoulet C, Charbonier A, Mozziconacci MJ, Birnbaum D, Chaffanet M, Vey N.
Collette Y, et al. Among authors: mozziconacci mj.
Blood Cancer J. 2015 Mar 13;5(3):e292. doi: 10.1038/bcj.2015.13.
Blood Cancer J. 2015.
PMID: 25768406
Free PMC article.
No abstract available.